Abstract

Multidrug‐resistant bacteria represent one of the biggest challenges facing modern medicine. The increasing prevalence of glycopeptide resistance compromises the efficacy of vancomycin, for a long time considered as the last resort for the treatment of resistant bacteria. To reestablish its activity, polycationic peptides were conjugated to vancomycin. By site‐specific conjugation, derivatives that bear the peptide moiety at four different sites of the antibiotic were synthesized. The most potent compounds exhibited an approximately 1000‐fold increased antimicrobial activity and were able to overcome the most important types of vancomycin resistance. Additional blocking experiments using d‐Ala‐d‐Ala revealed a mode of action beyond inhibition of cell‐wall formation. The antimicrobial potential of the lead candidate FU002 for bacterial infection treatments could be demonstrated in an in vivo study. Molecular imaging and biodistribution studies revealed that conjugation engenders superior pharmacokinetics.

Highlights

  • Vancomycin is the critical and decisive antibiotic for the treatment of multidrug-resistant infections caused by Grampositive bacteria.[6]

  • The highly cross-linked heptapeptide core structure of vancomycin minimizes the loss of conformational entropy upon binding, leading to micromolar binding affinities

  • Vancomycin represents a rare example of a small molecule with the capability of high

Read more

Summary

Introduction

Using sitefor low-molecular weight organic compounds, vancomycin is specific reactions, vancomycin could be modified at four capable of neutralizing the peptide moiety of the cell wall different sites, named VN, VR, VC, and VV (Scheme 2), precursor lipid II.[7] Ever since its discovery in 1958, vanco- resulting, for example, in the compounds FU002, FU007, mycin seemed to be a drug devoid of the threat of resistance FU008 or FU013

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.